Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlie Schmidt

Showing results (31-40 of 113) with videos related to

Pageof 12
Sort By:
Nature Biotechnology|April 12, 2011
Amgen spikes interest in live virus vaccines for hard-to-treat cancersCharlie Schmidt
Nature Biotechnology|November 10, 2006
Synthetic gene firms evolve toward sustainable business?Charlie Schmidt
Journal of the National Cancer Institute|September 7, 2006
Tissue banks trigger worry about ownership issuesCharlie Schmidt
Journal of the National Cancer Institute|December 21, 2006
Lack of progress in teen and young adult cancers concerns researchers, prompts studyCharlie Schmidt
Journal of the National Cancer Institute|December 21, 2006
5-year survival data not always a good measure of progressCharlie Schmidt
Nature Biotechnology|February 9, 2007
Profile: Jean-Paul ClozelCharlie Schmidt
Journal of the National Cancer Institute|July 28, 2018
Researchers Find Discrepancies in Gene Panel Tests for CancerCharlie Schmidt
Nature Biotechnology|January 10, 2009
Mark RothCharlie Schmidt
Journal of the National Cancer Institute|November 17, 2005
Latest HapMap update aims to direct researchers to genetic basis of diseaseCharlie Schmidt
Journal of the National Cancer Institute|July 9, 2018
New Guidelines Allow Some Patients With Chronic Myeloid Leukemia To Go Off TreatmentCharlie Schmidt
Pageof 12

Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
Nature Biotechnology|April 12, 2011
Amgen spikes interest in live virus vaccines for hard-to-treat cancersCharlie Schmidt
Nature Biotechnology|November 10, 2006
Synthetic gene firms evolve toward sustainable business?Charlie Schmidt
Journal of the National Cancer Institute|September 7, 2006
Tissue banks trigger worry about ownership issuesCharlie Schmidt
Journal of the National Cancer Institute|December 21, 2006
Lack of progress in teen and young adult cancers concerns researchers, prompts studyCharlie Schmidt
Journal of the National Cancer Institute|December 21, 2006
5-year survival data not always a good measure of progressCharlie Schmidt
Nature Biotechnology|February 9, 2007
Profile: Jean-Paul ClozelCharlie Schmidt
Journal of the National Cancer Institute|July 28, 2018
Researchers Find Discrepancies in Gene Panel Tests for CancerCharlie Schmidt
Nature Biotechnology|January 10, 2009
Mark RothCharlie Schmidt
Journal of the National Cancer Institute|November 17, 2005
Latest HapMap update aims to direct researchers to genetic basis of diseaseCharlie Schmidt
Journal of the National Cancer Institute|July 9, 2018
New Guidelines Allow Some Patients With Chronic Myeloid Leukemia To Go Off TreatmentCharlie Schmidt
Pageof 12